Chivabvu 2023: Omidubicel-onlv (Omisirge, Gamida Cell Ltd.) yakatenderwa neFood and Drug Administration kuti ishandiswe muvakuru nevana varwere (makore gumi nemaviri zvichikwira) vane hematologic malignancies avo vakarongerwa kuwana.